{"chunk_id": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue__chunk_18", "source": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue", "text": "Labeling for Human Prescription Drug and Biological Products- Content and Format  to assist drug \nmanufacturers in complying with the new labeling content and format requirements.  This draft guidance provides \nrecommendations to applicants in developing labeling for new products, revising existing labeling, and implementing the content \nand format requirements of the PLLR for human prescription drug and biological products. \nNote that regarding generic drugs, if the labeling of a reference list"}